Literature DB >> 10777610

PDZ domain-dependent suppression of NF-kappaB/p65-induced Abeta42 production by a neuron-specific X11-like protein.

S Tomita1, T Fujita, Y Kirino, T Suzuki.   

Abstract

It is widely believed that one of the causes of Alzheimer's disease (AD) is the generation and secretion of beta-amyloid (Abeta) from amyloid precursor protein in the brain. Here we report that a transcription factor, NF-kappaB/p65, induces increased secretion of amyloidogenic Abeta42 but not Abeta40. The kappaB motif-dependent production of Abeta42 was suppressed by binding of NF-kappaB/p65 to the PDZ domain of the X11-like protein (X11L), which a human homologue protein of LIN-10. The results suggest that the PDZ domain of X11L can control the ability of NF-kappaB/p65 to induce expression of protein(s) involved in Abeta42 production. The amino acids 161-163 in Rel homology domain (RHD) of NF-kappaB/p65 is important in interaction of NF-kappaB/p65 with X11L. Another subunit NF-kappaB/p50 and heterodimers of p65 and p50 do not bind to X11L. Our finding indicates NF-kappaB and X11L may, in novel way, regulate Abeta production in neuronal cells. Targeting X11L by specific therapy may provide the possibility to control the progression of AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777610     DOI: 10.1074/jbc.c000019200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Palmitate-induced C/EBP homologous protein activation leads to NF-κB-mediated increase in BACE1 activity and amyloid beta genesis.

Authors:  Gurdeep Marwarha; Jared Schommer; Jonah Lund; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2018-02-14       Impact factor: 5.372

2.  Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations.

Authors:  Linda Chami; Virginie Buggia-Prévot; Eric Duplan; Dolores Del Prete; Dolores Delprete; Mounia Chami; Jean-François Peyron; Frédéric Checler
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

3.  Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.

Authors:  Syaun Sung; Hengxuan Yang; Kunihiro Uryu; Edward B Lee; Lei Zhao; Diana Shineman; John Q Trojanowski; Virginia M-Y Lee; Domenico Praticò
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

4.  Novel mediators of amyloid precursor protein signaling.

Authors:  Andrzej Swistowski; Qiang Zhang; Mark E Orcholski; Danielle Crippen; Cathy Vitelli; Alexei Kurakin; Dale E Bredesen
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

5.  XB51 isoforms mediate Alzheimer's beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms.

Authors:  Akio Sumioka; Seiyu Imoto; Ralph N Martins; Yutaka Kirino; Toshiharu Suzuki
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 6.  Cytoplasmic tail adaptors of Alzheimer's amyloid-beta protein precursor.

Authors:  Masaoki Kawasumi; Shuji Matsuda; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

7.  X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.

Authors:  Jacqueline C Mitchell; Belall B Ariff; Darran M Yates; Kwok-Fai Lau; Michael S Perkinton; Boris Rogelj; John D Stephenson; Christopher C J Miller; Declan M McLoughlin
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

Review 8.  The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Claire L Palmer; Lucy Cotton; Jeremy M Henley
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

9.  Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans.

Authors:  Masayuki Ichioka; Takayoshi Suganami; Naoto Tsuda; Ibuki Shirakawa; Yoichiro Hirata; Noriko Satoh-Asahara; Yuri Shimoda; Miyako Tanaka; Misa Kim-Saijo; Yoshihiro Miyamoto; Yasutomi Kamei; Masataka Sata; Yoshihiro Ogawa
Journal:  Diabetes       Date:  2011-01-31       Impact factor: 9.461

10.  Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases.

Authors:  Monika Ray; Jianhua Ruan; Weixiong Zhang
Journal:  Genome Biol       Date:  2008-10-08       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.